Mast Therapeutics (MSTX) Reports Q4 Loss of $0.02/Share

Mast Therapeutics (NYSE: MSTX) reported Q4 EPS of ($0.02), versus ($0.06) reported last year.

For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery